Jorg Kohl MD

Jorg during the past 25 years, Jorg’s laboratory has been interested in the role of complement in acute and chronic inflammatory diseases. More specifically, he is interested in the regulatory networks between complement and other arms of innate immunity and the impact of this cross-talk on innate and adaptive immune responses. The focus is on the anaphylatoxic peptides C3a and C5a and their G-Protein-coupled receptors in experimental models of allergic asthma, autoimmune diseases, transplantation and infections.